Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Education program aims to boost cancer screening in blind women

NCT ID NCT07541859

First seen Apr 22, 2026 · Last updated Jun 22, 2026 · Updated 10 times

Summary

This study tests whether a special education program can increase breast and cervical cancer screening among visually impaired women. About 74 women over age 40 will receive training on cancer risks and how to schedule screenings. Researchers will check if screening rates and knowledge improve after the program.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Altınokta Association of the Blind

    Istanbul, Şişli, Turkey (Türkiye)

  • Turkish Association for the Blind

    Istanbul, Kadıköy, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Cancer Screening Awareness Education (behavioral intervention)

What this could lead to

If successful, this could show that tailored education helps visually impaired women get screened more often, potentially catching cancers earlier.

What could go wrong

This is a small, early-stage study with only 74 participants, so results may not apply broadly. It measures short-term changes, not long-term health outcomes.

Conditions

The condition(s) this trial relates to.

breast neoplasm Uterine Cervical Neoplasms uterine cervix neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.